Corbion NV - Company Profile
Powered by 
All the sales intelligence you need on Corbion NV in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Corbion NV fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Corbion NV.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Corbion NV (Corbion) manufactures and supplies biochemical, biomedical, bioplastic, and food ingredient solutions. The company’s product offerings include lactic acid and its derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients. It offers food solutions to various businesses such as bakeries, meat, confectionery, poultry, oils, dairy, seafood, shortening and margarine, beverages, fruits, and vegetables, refrigerated food and emulsifiers. Corbion caters to biochemical solutions for agrochemicals, pharma, animal health and nutrition, chemicals, home care, and personal care. The company markets its products under various brands such as AlgaPrime DHA, Starplex, Purac, AlgaVia, Verdad, Puracal, Nutrivan, and Ultra Fresh. It has operational presence in Asia, Latin America, North America and Europe, the Middle East, and Africa. Corbion is headquartered in Amsterdam, Noord-Holland, the Netherlands.
Headquarters
Netherlands
Address
Piet Heinkade 127, Amsterdam, 1019GM
Website
www.corbion.com
Telephone
31 20 5906911
No of Employees
2,408
Industry
Chemicals
Ticker Symbol & Exchange
CRBN (AMS)
Revenue (2024)
$1.4B
-1.6%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-61.1%
(2024 vs 2023)
Market Cap*
$1.3B
Net Profit Margin (2024)
XYZ
-60.5%
(2024 vs 2023)
* As of and is in US$
Corbion NV premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Food | Contract Manufacturing | Aloapur |
| Antioxidants | Custom Synthesis | Calfeed |
| Fermentation and Preservation Ingredients | Technical Services | Lafeed |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In August, the company signed a strategic partnership with Kuehnle AgroSystems to form and commercialize a high-quality, natural astaxanthin derived from non-GMO heterotrophic algae. |
| 2025 | Regulatory Approval | In July, the company secured Chinese regulatory approvals to introduce its premium algae-derived omega-3 DHA products into human and animal nutrition markets in China. |
| 2025 | Contracts/Agreements | In June, the company signed a partnership with Wageningen Food & Biobased Research and five other international partners to unlock fermented foods and postbiotics that can improve gut health and lower chronic low-grade inflammation. |
Competitor Comparison
| Key Parameters | Corbion NV | BASF SE | EIDP Inc | Akzo Nobel NV | DSM-Firmenich AG |
|---|---|---|---|---|---|
| Headquarters | Netherlands | Germany | United States of America | Netherlands | Switzerland |
| City | Amsterdam | Ludwigshafen | Indianapolis | Amsterdam | Kaiseraugst |
| State/Province | - | Rheinland-Pfalz | Indiana | - | Aargau |
| No. of Employees | 2,408 | 111,822 | 21,000 | 31,500 | 28,550 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Mathieu Vrijsen | Chairman | Executive Board | 2023 | 77 |
| Olivier Rigaud | Chief Executive Officer | Senior Management | 2023 | 61 |
| Peter Kazius | Chief Financial Officer | Senior Management | 2024 | 53 |
| Jacqueline van Lemmen | Chief Operating Officer | Senior Management | 2017 | 64 |
| Masha Vis-Mertens | Chief Human Resources Officer | Senior Management | 2024 | 54 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer